EMA Semaglutide MASH Verdict: Breakthrough Liver Drug Awaits Key Decision
The EMA semaglutide MASH verdict could mark a turning point in treating metabolic liver disease in Europe. The European Medicines…
Home »
Liver Disease
Semaglutide and Liver Health Breakthrough: New Hope for MASH Beyond Weight Loss
A major update for liver disease care has emerged from recent clinical research showing that semaglutide can improve liver outcomes…
Gut Bacteria Boosts Diabetes Drug to Fight Fatty Liver in Type 2 Diabetes
A recent study highlights a breakthrough approach to tackling fatty liver in type 2 diabetes. Researchers in China combined a…
GLP-1 Diabetes Drugs May Cut Liver Cancer Risk in Type 2 Diabetes, Studies Suggest
Emerging research suggests that glucagon-like peptide-1 (GLP-1) receptor agonists, widely prescribed drugs for type 2 diabetes , may also offer…
GLP-1 Drugs May Cut Liver Cancer Risk by 42% in People With Type 2 Diabetes
Emerging evidence suggests that diabetes medications known as GLP-1 receptor agonists (GLP-1 RAs) , widely prescribed for type 2 diabetes…
Beyond the Scales: Wegovy Linked to Liver Healing Benefits in New Analysis
A fresh analysis of the phase 3 ESSENCE trial has revealed that the weight-loss drug Wegovy (semaglutide 2.4 mg) could…
New Dual-Receptor Drug Shows Promise Against Fatty Liver and Obesity
A novel drug that activates both GLP-1 and glucagon receptors has demonstrated significant reductions in liver fat and body weight…
Semaglutide Gains Approval as First Treatment for Metabolic Dysfunction Associated with Liver Disease
A major advance in treating fatty liver disease has been announced: semaglutide (the GLP-1 medication best known via brands like…
Wegovy Wins FDA Approval for Treating Liver Disease
The US Food and Drug Administration (FDA) has granted approval for Wegovy, an injectable form of semaglutide, to treat adults…
Novo Nordisk Shares Surge on Wegovy’s FDA Approval for Liver Disease: A Comprehensive Analysis
Novo Nordisk, a global healthcare company with a century-long legacy, has consistently been at the forefront of developing innovative treatments…
